Concepedia

Masaaki Ogasa

MO

7

Publications

1.2K

Citations

7

H-Index

2009

Active since

Affiliations

Sunovion (United States)(Current)

Kanazawa University

Vion Pharmaceuticals (United States)

Sumitomo Dainippon Pharma (Japan)

University of Miami

Masaaki Ogasa is an author at Sunovion (United States) specializing in social sciences, psychiatry, and clinical psychiatry.

Top concepts

Publications per year

2009–2015

7

Publications

7

Pharmacological Profile of Lurasidone, a Novel Antipsychotic Agent with Potent 5-Hydroxytryptamine 7 (5-HT7) and 5-HT1A Receptor Activity

Tadashi Ishibashi, Tomoko Horisawa, Kumiko Tokuda et al. · Journal of Pharmacology and Experimental Therapeutics · 2010 · 422 citations

Lurasidone in the Treatment of Schizophrenia: A Randomized, Double-Blind, Placebo- and Olanzapine-Controlled Study

Herbert Y. Meltzer, Josephine Cucchiaro, Robert Silva et al. · American Journal of Psychiatry · 2011 · 248 citations

Lurasidone in the Treatment of Acute Schizophrenia

Mitsutaka Nakamura, Masaaki Ogasa, John Guarino et al. · The Journal of Clinical Psychiatry · 2009 · 192 citations

Lurasidone in the treatment of schizophrenia: a 6-week, placebo-controlled study

Masaaki Ogasa, Tatsuya Kimura, Mitsutaka Nakamura et al. · Psychopharmacology · 2012 · 116 citations · Full text

Performance and interview-based assessments of cognitive change in a randomized, double-blind comparison of lurasidone vs. ziprasidone

Philip D. Harvey, Masaaki Ogasa, Josephine Cucchiaro et al. · Schizophrenia Research · 2011 · 95 citations

, , +8

Rows per page

1–5 of 7